SOCS2, MYOM2, FTCD, ADAMTSL2, TMEM106C, LARS, and KPNA2 are vital biomarkers and involved in the process of the HCC prognosis and immune infiltration. This evidence concerns the gene FTCD and hepatocellular carcinoma.